Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
**Objectives:** To evaluate the total and outpatient economic burden of aspergillosis, and to describe the outpatient antifungal treatment of aspergillosis within a large, commercially-insured population in the United States. **Methods:** Adults with at least one medical claim with an aspergillosis...
Saved in:
Main Authors: | Emily Durden, Donna McMorrow, Paul Juneau, Robert Fowler, Paresh Chaudhari, David Horn |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2013-10-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9862 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis
by: Takahiro Takazono, et al.
Published: (2024-12-01) -
Invasive Aspergillosis in the Intensive Care Unit
by: Anna Zubovskaia, et al.
Published: (2025-01-01) -
Costs of outpatient services at selected primary healthcare centers in Bangladesh: A cross-sectional study.
by: Md Zahid Hasan, et al.
Published: (2025-01-01) -
Prevalence and features of allergic bronchopulmonary aspergillosis, United States, 2016-2022.
by: Kaitlin Benedict, et al.
Published: (2025-01-01) -
Prevalence and features of allergic bronchopulmonary aspergillosis, United States, 2016–2022
by: Kaitlin Benedict, et al.
Published: (2025-01-01)